Pay in 4 interest-free payments of $6.28 Learn more
Ships within 48 hours · Estimated delivery Aug 8 - Aug 13
Epub 2014 Apr 22
PMCID: PMC10136111
Obesity-related asthma typically manifests as a conglomerate of interconnected immuno-metabolic systems and may therefore benefit from shared therapeutic interventions, such as glucagon-like peptide-1 (GLP-1) agonism
5-Amino-1MQ operates as an inhibitor of nicotinamide N-methyltransferase (NNMT), an enzyme central to regulating nicotinamide metabolism and intracellular NAD+ levels
Eur J Pharmacol 2015
Front Endocrinol (2022) 13:886451
US$ 20.01
US$ 29.72
US$ 21.39
US$ 23.76
US$ 25.43
US$ 22.56
US$ 23.41
US$ 20.58
